Blog Posts
Mike Thompson
Mike Thompson/LinkedIn

Mike Thompson: Myeloma/Plasma Cell Dyscrasia – Top Abstract Highlights from ASH24

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared a post on X:

 “Myeloma/Plasma Cell Dyscrasia ~ ASH24Top10 (or so) Multiple Myeloma ASH24 by Mike Thompson

*DRAFT* Table Update: Nov 20, 2024″

Mike Thompson: Myeloma/Plasma Cell Dyscrasia - Top Abstract Highlights from ASH24

 

ASH24 cancer Cell Dyscrasia Joseph Mikhael Mike Thompson multiple myeloma Myeloma OncoDaily Oncology Samer Al Hadidi Tempus